AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma.

AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma.

Despite multidisciplinary therapy, the prognosis is poor for esophageal squamous cell carcinoma (ESCC). In the locally advanced stage, neoadjuvant chemoradiotherapy (nCRT) followed by surgery could provide survival benefits to some patients. Here, we aimed to identify for tumor therapy response a bi...

Full description

Bibliographic Details
Main Authors: Chih-Hung Lin, Han-Ni Chuang, Tzu-Hung Hsiao, V Bharath Kumar, Chiung-Hung Hsu, Chih-Yang Huang, Li-Wen Lee, Chien-Lin Mao, Jiunn-Liang Ko, Chung-Ping Hsu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0276990

Internet

https://doi.org/10.1371/journal.pone.0276990

Similar Items